The main shareholder of Baotou Dongbao Bio-tech (300239.SZ), China Shengyuan, has completed the reduction of 1.998% of its shares.

13/11/2024

GMT Eight

Baotou Dongbao Bio-tech (300239.SZ) announcement, the company's shareholder Hainan Baina Shengyuan Technology Co., Ltd. ("Baina Shengyuan") has cumulatively reduced its holdings of the company's shares by 11.86 million shares, accounting for 1.998% of the total share capital. This reduction plan has been terminated ahead of schedule.

Chengdu Kanghua Biological Products(300841.SZ)Three shareholders plan to collectively reduce their holdings by no more than 3.3% of the shares.

Hong Kong Stock Exchange: Financial markets will continue to operate fully despite the impact of the typhoon.

Contact: contact@gmteight.com

The main shareholder of Baotou Dongbao Bio-tech (300239.SZ), China Shengyuan, has completed the reduction of 1.998% of its shares.

RECOMMEND

Hunan Jingfeng Pharmaceutical (000908.SZ) has accumulated an increase of 752.78%, and will be halted for verification starting on November 18th.

Anhui Huaertai Chemical (001217.SZ): 189 million restricted shares will be listed for trading on November 21, accounting for 56.8494% of the total share capital.

ZYF Lopsking Material Technology (002333.SZ): Chen Xingcan collectively reduced its holdings by 0.79%, with holdings less than 5%.